Monique L. den Boer

MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia

Scott A. Armstrong, Jane Staunton, Lewis B. Silverman et al. · Nature Genetics · 2001 · 1.7K citations

Hematological Malignancy, Chromatin, Distinct Gene Expression +12

A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study

Monique L. den Boer, Marjon van Slegtenhorst, Renée X. de Menezes et al. · The Lancet Oncology · 2009 · 915 citations · Full text

Hematological Malignancy, Poor Treatment Outcome, Pediatric Hematology +12

Gene-Expression Patterns in Drug-Resistant Acute Lymphoblastic Leukemia Cells and Response to Treatment

Amy de Haar-Holleman, Meyling Cheok, Monique L. den Boer et al. · New England Journal of Medicine · 2004 · 643 citations · Full text

Gene expression-based chemical genomics identifies rapamycin as a modulator of MCL1 and glucocorticoid resistance

Guo Wei, David Twomey, Justin Lamb et al. · Cancer Cell · 2006 · 512 citations · Full text

Natural Sciences, Molecular Biology, Resistance Mutation (Virology) +8

Inhibition of FLT3 in MLL

Scott A. Armstrong, Andrew L. Kung, Meghann E. Mabon et al. · Cancer Cell · 2003 · 398 citations · Full text

Molecular Pharmacology, Molecular Regulation, Medicine +5